Medtech Market Dynamics and Challenges​

From medical devices, diagnostics and tools companies to digital health and convergence opportunities with biopharma, the medtech space is experiencing a major growth movement in terms of innovation, globalization and access to capital. There have been an increasing number of FDA approvals and medtech companies have experienced a strong private fundraising market, which has been further strengthened by global investors. IPO activities are trending toward revenue-generating companies and M&A activity continues to support industry consolidation for both emerging product-based companies as well as large strategic medtechs.

Enter Locust Walk

For a medical device, diagnostic, instrument, or medical technology, understanding the utility and need for a particular product as well as analyzing and validating the commercial market is often key to landing a financing or high-value exit. Locust Walk is uniquely positioned to assist in all these areas.

There is great excitement for medtech companies approaching their first-in-man or initial regulatory clearance. These companies benefit from Locust Walk’s business acumen, added bandwidth, and ability to run a strategic or financing process. We’re able to recommend potential investors and alternative funding sources, such as family offices, to execute on the transactions needed to get these companies to the next step in their evolution.

As companies advance toward market, we typically continue an engagement to create a market demand and find the best price and identify potential alternative buyers and investors to fully realize the potential of their products.

On the buy side, many private equity-backed or small cap public companies with one or more marketed products are hungry for commercial stage deals to more quickly accelerate their growth trajectory. We collaborate with these companies to identify and transact target assets and companies to build out their commercial portfolios with complimentary products acquired at the right price.